cAMP-GEF cytoprotection by Src tyrosine kinase activation of phosphoinositide-3-kinase p110 β/α in rat hepatocytes

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 4, 2009, Pages

  Gates, Anna ^a   Hohenester, Simon ^a,b   Anwer, M Sawkat ^a   Webster, Cynthia R L ^a  

^a TUFTS UNIVERSITY   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Akt; Bile acids; cAMP binding guanine nucleotide exchange factors; EGF receptor; Rap

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 CHLORO PHENYLTHIO) 2' O METHYLADENOSINE 3' 5' CYCLIC MONOPHOSPHATE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CYCLIC AMP; CYCLIC AMP DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOCHENODEOXYCHOLIC ACID; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P110; PROTEIN P110 ALPHA; PROTEIN P110 BETA; PROTEIN SUBUNIT; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; ISOENZYME; P110DELTA PROTEIN, RAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HYDROPHOBICITY; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CYCLIC AMP; GENE EXPRESSION REGULATION; GLYCOCHENODEOXYCHOLIC ACID; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HEPATOCYTES; ISOENZYMES; MALE; RATS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 67149102230     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90622.2008     Document Type: Article

References (64)

1. Andre C, Couton D, Gaston J, Erraji L, Renia L, Varlet P, Brian P, Guillet J. Alpha 2-adrenergic receptor selective agonist clenbuterol prevents Fas mediated liver apoptosis and death in mice. Am J Physiol Gastrointest Liver Physiol 276: G647-G654, 1999.
2. Arcaro A, Aubert M, Espinosa del Hierro ME, Khanzada UK, Angelidou S, Tetley TD, Bittermann AG, Frame MC, Seckl M. Critical role for lipid raft associated Src kinases in activation of PI3K-Akt signaling. Cell Signal 19: 1081-1092, 2007.
3. Barbier AJ, Poppleton HM, Yigzaw Y, Mullenix JB, Wiepz GJ, Bertics PJ, Patel TB. Transmodulation of epidermal growth factor receptor function by cyclic AMP-dependent protein kinase. J Biol Chem 274: 14067-14073, 1999.
4. Bertelsen LS, Barrett KE, Keely SJ. Gs protein-coupled receptor agonists induce transactivation of the epidermal growth factor receptor in T84 cells: implications for epithelial secretory responses. J Biol Chem 279: 6271-6279, 2004.
5. Beuers U, Denk GU, Soroka CJ, Wimmer R, Rust C, Paumgartner G, Boyer JL. Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase dependent mechanisms in perfused rat livers, and rat hepatocytes couplets. J Biol Chem 278: 17810-17818, 2003.
6. Brachmann SM, Yballe CM, Innocenti M, Deane JA, Fruman DA, Thomas SM, Cantley LC. Role of phosphoinositide 3-kinase regulatory isoforms in development, and actin rearrangement. Essential role of PI3K-p110 beta in cell growth, metabolism and tumorigenesis. Mol Cell Biol 25: 2593-2606, 2005.
7. Carini R, Alchera E, Baldanzi G, Piranda D, Splendores R, Grazia De Cesaris M, Caraceni P, Grasiani A, Albano E. Role of p38 map kinase in glycine-induced hepatocyte resistance to hypoxic injury. J Hepatol 46: 692-699, 2007.
8. Carini R, Grazia de Cesaris M, Splendore R, Baldanzi G, Nitti MP, Alchera E, Filigheddu N, Domenicotti C, Pronzato MA, Graziani A, Albano E. Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. Gastroenterology 127: 914-923, 2004.
9. Carmona-Cuenca I, Herrera B, Ventura JJ, Roncero C, Fernandez M, Fabregat I. EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death. J Cell Physiol 207: 322-330, 2006.
10. Chen K, Vita JA, Berk BC, Keaney JF. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves Src-dependent epidermal growth factor receptor transactivation. J Biol Chem 276: 16045-16050, 2001.
11. Cuevas B, Lu Y, Mao M, Zhang J, LaPushin R, Siminovitch K, Mills GB. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphoinositol 3-kinase. J Biol Chem 276: 27455-27461, 2001.
12. Cullen K, McCool J, Anwer MS, Webster CRL. Activation of cAMP-guanine exchange factor (cAMP-GEF) confers protein kinase A independent protection from hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol 287: G334-G343, 2004.
13. De Gregorio G, Coppa A, Cosentino C, Ucci S, Messina S, Nicolussi A, D'Inzeo S, DiPardo A, Avvedimento EV, Porcellini A. The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals. Oncogene 26: 2039-2047, 2007.
14. DeToni EN, Kuntzen C, Gerbes AL, Thasler WE, Sonoc N, Mucha SR, Camaj P, Bruns C, Goke B, Eichhorst ST. p60-c-src suppresses apoptosis through inhibition of caspase 8 activation in hepatoma cells, but not in primary hepatocytes. J Hepatol 46: 682-691, 2007.
15. Diehl A, Yang S, Wand G. Chronic ethanol consumption disturbs G-protein expression and inhibits cyclic AMP dependent signaling in regenerating liver. Hepatology 16: 1212-1219, 1992.
16. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619, 2006.
17. Foukas LC, Claret M, Pearce W, Okkenhaug K, Meek S, Peskett E, Sancho S, Smith AJ, Withers DJ, Vanhaesebroeck B. Critical role for the p110 alpha phosphoinositide 3-OH kinase in growth and metabolic regulation. Nature 441: 366-370, 2006.
18. Gantner F, Küsters S, Wendel A, Hatzelmann A, Schudt C, Tiegs G. Protection from T cell mediated murine liver failure by phosphodiesterase inhibitors. J Pharmacol Exp Ther 280: 53-60, 1997.
19. Glaser S, Alvaro D, Francis H, Ueno Y, Marucci L, Benedetti DeMorrow S A, Marzioni M, Mancino MG, Phinizy JL, Reichenback R, Fava G, Summers R, Venter J, Alpini G. Adrenergic receptor agonists prevent bile duct injury by adrenergic denervation by increased cAMP levels and activation of Akt. Am J Physiol Gastrointest Liver Physiol 290: G813-G826, 2006.
20. Gobejishvili L, Barve S, Joshi-Barve S, Uriarte S, Song Z, McClain C. Chronic ethanol mediated decreases in cAMP primes macrophages to enhanced LPS inducible NF-κB activity and TNF expression: relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 291:G681-G688, 2006.
21. Graf D, Reinehr R, Kurz AK, Fishcer R, Haussinger D. Inhibition of taurolithocholate 3-sulfate-induced apoptosis by cyclic AMP in rat hepatocytes involves protein kinase A-dependent and -independent mechanisms. Arch Biochem Biophys 415: 34-42, 2003.
22. Graupera M, Guillermet-Guibert J, Foukas LC, Phng LK, Cain RJ, Salpekar A, Pearce W, Meek S, Millan J, Cutillas PR, Smith AJ, Ridley AJ, Ruhrberg C, Gerhardt H, Vanhaesebroeck B. Angiogenesis selectively requires the p110α isoform of PI3K to control cell migration. Nature 453: 662-666, 2008.
23. Han C, Bowen WC, Michalopoulos GK, Wu T. Alpha-1 adrenergic receptor transactivates signal transducer and activator of transcription-3 (Stat3) through activation of Src and epidermal growth factor receptor (EGFR) in hepatocytes. J Cell Physiol 216: 486-497, 2008.
24. Harbrecht BG, Perpetua M, Fulmer M, Zhang B. Glucagon regulates hepatic inducible nitric oxide synthesis in vivo. Shock 22: 157-162, 2004.
25. Hohenester S, Gates A, Beuers U, Anwer S, Webster CRL. Differential activation of Class IA phosphoinositide-3 kinase p110 isoforms by bile acids: role of p110 γ activation in hepatocyte apoptosis (Abstract). Hepatology 46: 254, 2007.
26. Holz GC, Kang G, Harbeck M, Roe MW, Chepurny OG. Cell physiology of Epac. J Physiol 577: 5-15, 2006.
27. Ikegami T, Kriloy L, Meng J, Patel B, Chapin-Kennedy K, Bouscarel B. Decreased glucagon responsiveness by bile acids: a role for protein kinase C alpha and glucagon receptor phosphorylation. Endocrinology 147: 5294-5302, 2006.
28. Ishikawa H, Jin MB, Ogata T, Taniguchi M, Sukuki T, Shimamura T, Magata S, Horiuchi H, Ogata K, Masuko H, Fujita M, Furukawa H, Todo S. Role of cyclic nucleotides in ischemia and reperfusion injury of canine livers. Transplantation 73: 1041-1048, 2002.
29. Jackson SP, Schoenwaelder SM, Goncalves I, Nesbitt WS, Yap CL, Wright CE, Kenche V, Anderson KE, Dopheide SM, Yuan Y, Sturgeon SA, Prabaharan H, Thompson PE, Smith GD, Shepherd PR, Daniele N, Kulkarni S, Abbott B, Saylik D, Jones C, Lu L, Giuliano S, Hughan SC, Angus JA, Robertson AD, Salem HH. PI3-kinase p110 beta: a new target for anti-thrombotic therapy. Nat Med 11: 507-514, 2005.
30. Jia S, Liu Z, Zhang S, Liu P, Zhang L, Lee SH, Zhang J, Signoretti S, Loda M, Roberts TM, Zhao JJ. Essential roles of PI(3)K-p110β in cell growth, metabolism, and tumorigenesis. Nature 454: 776-779, 2008.
31. Kagawa T, Varticovski L, Sai Y, Arias IM. Mechanism by which cAMP activates PI3-kinase and increases bile acid secretion in WIF-B9 cells. Am J Physiol Cell Physiol 283: C1655-C1666, 2002.
32. Kume M, Banafsche R, Yamamoto Y, Yamoaka Y, Nobiling R, Gebhard MM, Klar E. Dynamic changes of post-ischemic hepatic microcirculation improved by a pretreatment of phosphodiesterase-3 inhibitor, milrinone. J Surg Res 136: 209-218, 2006.
33. Kwak JHJ, Park KM, Choi HE, Chung KS, Lim HJ, Park HY. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways. Cell Signal 20: 803-814, 2008.
34. Kwon G, Pappan KL, Marshall C, Schaffer JE. cAMP dose-dependently prevents palmitate induced apoptosis by both protein kinase A and cAMP guanine nucleotide exchange factor dependent pathways in beta cells. J Biol Chem 279: 8938-8945, 2004.
35. Lesma E, Grande V, Di Giulio AM, Castellana P, Crosignani A, Cerri A, Gorio A. G-protein mediated signal transduction is affected in primary biliary cirrhosis. Hepatol Res 35: 45-52, 2006.
36. Li J, Yang S, Billiar TR. Cyclic nucleotides suppress tumor necrosis factor alpha-mediated apoptosis by inhibiting caspase activation and cytochrome c release in primary hepatocytes via a mechanism independent of Akt activation. J Biol Chem 275: 13026-13034, 2000.
37. Li Z, Mizuno S, Nakamura T. Anti-necrotic and anti-apoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases. Am J Physiol Gastrointest Liver Physiol 292: G639-G646, 2007.
38. Liu X, Marengere LE, Koch CA, Pawson T. The v-Src SH3 domain binds phosphatidylinositol 3′-kinase. Mol Cell Biol 13: 5225-5232, 1993.
39. Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurrany JS, Fang X, Yung WK, Siminovitch KA, Mills GB. Src family protein tyrosine kinases alter the function of PTEN to regulate phosphatidyl 3-kinase/Akt cascades. J Biol Chem 278: 40057-40066, 2003.
40. Macrez N, Mironneau C, Carricaburu V, Quignard JF, Babich A, Czupalla C, Nürnberg B, Mironneau J. Phosphoinositide 3-kinase isoforms selectively couple receptors to vascular L-type Ca (2+) channels. Circ Res 89: 692-699, 2001.
41. Mei F, Qiao J, Tsygankova O, Meinkoth F, Quilliam L, Cheng X. Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP dependent protein kinase on protein kinase B activation. J Biol Chem 277: 11497-11504, 2002.
42. Misra S, Varticovski L, Arias I. Mechanism by which cAMP increases bile acid secretion in rat liver and canalicular membrane vesicles. Am J Physiol Gastrointest Liver Physiol 285: G316-G324, 2003.
43. Misra UK, Kaczowka S, Pizzo SV. The cAMP-activated GTP exchange factor, Epac1 upregulates plasma membrane and nuclear Akt kinase activities in 8-CPT-2-O-Me-cAMP-stimulated macrophages: gene silencing of the cAMP-activated GTP exchange Epac1 prevents 8-CPT-2-OMe-cAMP activation of Akt activity in macrophages. Cell Signal 20: 1459-1470, 2008.
44. Murillo MM, del Castillo G, Sanchez A, Fernandez M, Fabregat I. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes. Oncogene 24: 4580-4587, 2005.
45. Nitta T, Kim JS, Mohunczy D, Behrns KE. Murine cirrhosis induces hepatocytes epithelial mesenchymal transition and alterations in survival signaling pathways. Hepatology 48: 909-919, 2008.
46. Obara Y, Labudda K, Dillon TJ, Stork PJ. PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci 117: 6085-6094, 2004.
47. Piiper A, Dikic I, Lutz MP, Leser J, Kronenberger B, Elez R, Cramer H, Müller-Esterl W, Zeuzem S. Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells. J Biol Chem 277: 43623-43630, 2002.
48. Pleiman CM, Hertz WM, Cambier J. Activation of phosphatidylinositol-3′ kinase by Src family kinase SH3 binding to p85 subunit. Science 263: 1609-1612, 1994.
49. Reinehr R, Becker S, Wettstein M, Haussinger D. Involvement of the Src family kinase yes in bile salt-induced apoptosis. Gastroenterology 127: 1540-1557, 2004.
50. Rodriguez-Viciana P, Sabatier C, McCormick F. Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol 24: 4943-4954, 2004.
51. Rohrbach A, Rubio I, Bulgay-Moerschel M, Koenig C, Poehlmann TG, Markert UR, Gruen M. Selective downregulation of phosphoinositide 3-kinase alpha in leukocytes during pregnancy. Am J Reprod Immunol 61: 130-135, 2009.
52. Ruckle T, Schwarz MK, Rommel C, Clump DA, Oazi IH, Sudol M, Flynn DC. PI3Kgamma inhibition: towards an 'aspirin of the 21st century'? Nat Rev Drug Discov 5: 903-918, 2006.
53. Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, Haisma HJ, Jensen PL, Moshage H. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39:1563-1573, 2004.
54. Schulze-Bergkamen H, Brenner D, Krueger A, Suess D, Fas SC, Frey CR, Dax A, Zink D, Büchler P, Müller M, Krammer PH. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology 39: 645-654, 2004.
55. Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL. Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase. J Biol Chem 278: 31807-31813, 2003.
56. Sinclair EM, Yusta B, Streutker C, Baggio LL, Koehler J, Charron MJ, Drucker DJ. Glucagon receptor signaling is essential for control of murine hepatocyte survival. Gastroenterology 135: 2096-2106, 2008.
57. Takano M, Arai T, Mokuno Y, Nishimura H, Nimura Y, Yoshikai Y. Dibutyryl cyclic adenosine monophosphate protects mice against tumor necrosis factor induced hepatocyte apoptosis accompanied by increased heat shock protein 70 expression. Cell Stress Chaperones 3: 109-116, 1998.
58. Thomas S, Brugge J. Cellular function regulated by Src family kinase. Annu Rev Cell Dev Biol 13: 513-609, 1997.
59. Tiwari S, Felekkis K, Moon EY, Sherr DH, Lerner A. Among circulating hematopoietic cells, B-CLL, uniquely expresses functional EPAC1, but EPAC 1-mediated Rap 1 activation does not account for PDE4 inhibitor induced apoptosis. Blood 103: 2661-2667, 2004.
60. Trevino JG, Summy JM, Gallick GE. SRC inhibitors as potential therapeutic agents for human cancers. Mini Rev Med Chem 6: 681-687, 2006.
61. Webster CRL, Usechak P, Anwer MS. cAMP inhibits bile acid induced apoptosis by blocking caspase activation and cytochrome c release. Am J Physiol Gastrointest Liver Physiol 283: G727-G738, 2002.
62. Webster CR, Anwer MS. Phosphoinositide 3-kinase, but not mitogen-activated protein kinase, pathway is involved in hepatocyte growth factor-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology 33: 608-615, 2001.
63. Yano N, Suzuki D, Endoh M, Zhao TC, Padbury JF, Tseng YT. A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells. J Biol Chem 282: 18819-18830, 2007.
64. Yano N, Ianus V, Zhao TC, Tseng A, Padbury JF, Tseng YT. A novel signaling pathway for β-adrenergic receptor mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes. Am J Physiol Heart Circ Physiol 293: H385-H393, 2007.